XBiotech Inc. (XBIT) NASDAQ
2.41
+0.03(+1.26%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.41
+0.03(+1.26%)
Currency In USD
| Market Cap | 72.87M |
| Enterprise Value | -52.69M |
| P/E Ratio | -1.83 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.54 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.07 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.29 |
| Return On Equity | -0.26 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.69M |
| EBITDA | -54M |
| Net Income | -45.54M |
| Diluted EPS | -1.49 |
| Total Cash | 115.46M |
| Total Cash/Share | 3.79 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 39.03 |
| Book Value Per Share | 4.43 |
| 52-Week Change | -15.73 |
| 52-Week High | 3.61 |
| 52-Week Low | 2.09 |
| Moving Average 50 Days | 2.43 |
| Moving Average 200 Days | 2.53 |
| Average Volume | 33,104 |
| Shares Outstanding | 30.49M |
| % Held by Institutions | 6.54 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |